Cellmic, LLC

Medtech · Acquired

Microfluidics-based point-of-care diagnostic platform with integrated reader and HIPAA-compliant telemonitoring system for rapid detection of Ebola and Marburg filoviruses from minimal blood samples

cellmic.com →
Grants
$2.5M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$1.3M
4 awards · Defense, State, Health and Human S
#278 of 4531 in medtech
Patents
2
2 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Igf::ot::igf First Month Technical Progress Report$149,800
Federal contractDepartment of Defense · Igf::ot::igf First Monthly Technical Report$957,926
Federal contractDepartment of State · Ceo Neven Karlovac-chromatographic Reader Igf::ot::igf-for Other Functions.$8,163
Federal contractDepartment of Health and Human Services · Igf::ot::igf Tele-monitoring For Infectious Diseases: A Remote System For Assessing Patient Parameters And Specimen Analysis$224,661
Federal grantDepartment of Defense · Phase II · Global Spatiotemporal Disease Surveillance System$999,629
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
275YOU TUNE HEARING PROTECTION LLC$1.4M—
276Turner Innovations L.C.$1.3M—
277SEDIA BIOSCIENCES CORPORATION$1.3M$285K
278Cellmic, LLC$1.3M—
279Pharmaseq, Inc$1.3M—
280LUMENASTRA$1.3M—
281InnSight Technology, Inc$1.3M$120K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.